New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - deflazacort 30mg;  ;   - tablet - 30 mg - active: deflazacort 30mg     excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - deflazacort 6mg;  ;   - tablet - 6 mg - active: deflazacort 6mg     excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose sucrose

Egypt - English - EDA (Egyptian Drug Authority)

global napi - tablet - 6 mg

Egypt - English - EDA (Egyptian Drug Authority)

global napi - tablet - 30 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

shire pharmaceuticals ltd - deflazacort - oral tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

shire pharmaceuticals ltd - deflazacort - oral tablet - 30mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

advanced chemical industries limited - deflazacort - tablet - 24 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

beacon pharmaceuticals plc - deflazacort - suspension - 120 mg/100 ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

drug international ltd., squib road - deflazacort - tablet - 6 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

square pharmaceuticals plc, pabna - deflazacort - suspension - 120 mg/100 ml